CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$2.03
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+735.0% upside
Low Target
$12.65
Average Target
$16.95
High Target
$22.59
Current Price
$2.03
Current
$2.03
$2.03
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Scenario Analysis
Bear Case
$12.65
523.2%
Low target
Base Case
$16.95
+735.0%
Avg target
Bull Case
$22.59
+1,012.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$14.64
-86.1% from high
52-Week Low
$1.86
+9.1% from low
Target vs 52W High
$16.95
+15.8% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-1.45
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals